There Are 3,5 Million People Carrying Hepatitis B Virus in Turkey

There are millions of people in Turkey with hepatitis B virus.
There are millions of people in Turkey with hepatitis B virus.

Abdi İbrahim Medical Directorate draws attention to the viral hepatitis infection disease, which causes diseases such as cirrhosis, hepatocellular carcinoma and causes 28 deaths worldwide every year, on July 700, World Hepatitis Day. There are approximately 3.5 million hepatitis B virus carriers in Turkey.

Abdi İbrahim Medical Directorate draws attention to viral hepatitis that causes cirrhosis and liver cancer by causing inflammation in the liver, which affects 28 million people all over the world and causes 250 deaths every year, in a statement made on the occasion of July 700, World Hepatitis Day. Abdi İbrahim Medical Directorate underlines that Turkey is one of the middle endemic regions of the world with approximately 3.5 million hepatitis B virus carriers.

Although it has been estimated that the hepatitis B virus infects people and causes disease since ancient times, it is known that Hippocrates included observations of jaundice even in his daily practice. Today, the following information is included in the researches: ''The absence of symptoms of the disease in most individuals with hepatitis B virus in their blood causes the disease to remain undiagnosed and untreated for a long time. Only 11% of hepatitis B patients are aware that they carry the hepatitis B virus. Complications caused by hepatitis and hepatitis B can be prevented if diagnosed early. For this reason, it is of great importance to take preventive measures such as vaccines in the fight against hepatitis, to identify risk groups by screening, to raise awareness in different layers of society and health professionals, to ensure early detection of the disease and to follow up with appropriate treatment. Screening is recommended for people with symptoms and signs of acute or chronic hepatitis and for groups who are asymptomatic and at risk for HBV infection. In this disease, which is likely to become chronic, once-daily drug therapy is possible in order to prevent complications that can lead to death. Not much, but a huge leap forward compared to the challenging treatments for the disease about 20 years ago.”

On July 28, which was declared as World Hepatitis Day in memory of the US doctor Baruch Samuel Blumberg, who won the Nobel Prize in Medicine and Physiology by identifying the hepatitis B surface antigen (HbsAg), there are calls to raise awareness about the disease globally.

Hepatitis B disease has been included in the elimination program by WHO

Announcing that this disease, which can be controlled, is included in the 2030 elimination program of the World Health Organization (WHO), Abdi İbrahim Medical Directorate said that the number of new cases is reduced within the scope of the "Turkey Viral Hepatitis Prevention and Control Program (2018-2023)" of the Ministry of Health of the Republic of Turkey. Reminds you to work. It is stated that with the study, it is planned to reduce the deaths due to the disease, to improve the care of the diagnosed patients, and to reduce the socioeconomic impact of viral hepatitis in social areas.

Günceleme: 26/07/2021 12:26

Similar Ads

Be the first to comment

Leave a response

Your email address will not be published.